|
C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O)N |
Approved |
Phase shift modulation and period regulation via adenosine receptor signaling (in mice and mammals)
|
Adenosine A1, A2A, A2B, and A3 Receptors
|
Activation of Adenosine Receptors
|
Jagannath, A., Varga, N., Dallmann, R., Rando, G., Gosselin, P., Ebrahimjee, F., Taylor, L., Mosneagu, D., Stefaniak, J., Walsh, S. and Palumaa, T., 2021. Adenosine integrates light and sleep signalling for the regulation of circadian timing in mice. Nature communications, 12(1), p.2113.
|
|
CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C |
Approved |
Affects melatonin synthsis,
increases melatonin synthesis
|
GABAA receptors
|
GABA A receptor binding,
GABAergic system influence
|
Morera, A.L., Abreu-Gonzalez, P. and Henry, M., 2009. Zaleplon increases nocturnal melatonin secretion in humans. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 33(6), pp.1013-1016.
|
|
C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)O)C)C)[C@@H]2[C@H]1C)C)C(=O)O |
Not approved |
Modulation of clock gene expression and metabolic rhythm regulation in liver (in mammals)
|
ROR gamma
|
PTEN,
ROCK,
p53
|
Kojetin, D.J. and Burris, T.P., 2014. REV-ERB and ROR nuclear receptors as drug targets. Nature reviews Drug discovery, 13(3), pp.197-216.
,
Kwon, E.Y., Shin, S.K. and Choi, M.S., 2018. Ursolic acid attenuates hepatic steatosis, fibrosis, and insulin resistance by modulating the circadian rhythm pathway in diet-induced obese mice. Nutrients, 10(11), p.1719.
,
Zahran, E.M., Mohamad, S.A., Elsayed, M.M., Hisham, M., Maher, S.A., Abdelmohsen, U.R., Elrehany, M., Desoukey, S.Y. and Kamel, M.S., 2024. Ursolic acid inhibits NF-κB signaling and attenuates MMP-9/TIMP-1 in progressive osteoarthritis: a network pharmacology-based analysis. RSC advances, 14(26), pp.18296-18310.
|
|
CC1=CC(=NO1)NS(=O)(=O)C2=CC=C(C=C2)N |
Approved |
Circadian phase shift and dysrhythmia in eclosion rhythm in Drosophila melanogaster
|
mPer2
,
mPer1
,
CRY1-PER2 complex
,
CRY1
,
CLOCK-BMAL1
|
Core clock suppression
|
Yu, Z., Shen, J., Li, Z., Yao, J., Li, W., Xue, L., Vandenberg, L.N. and Yin, D., 2020. Obesogenic effect of sulfamethoxazole on Drosophila melanogaster with simultaneous disturbances on eclosion rhythm, glucolipid metabolism, and microbiota. Environmental Science & Technology, 54(9), pp.5667-5675.
|
|
CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)O)O)O)C(C)O |
not approved |
alone caused a long circadian period. However, the degree of lengthening was less than with Fe deficiency alone
|
Fe deficiency
|
Unknown
|
Chen, Y.Y., Wang, Y., Shin, L.J., Wu, J.F., Shanmugam, V., Tsednee, M., Lo, J.C., Chen, C.C., Wu, S.H. and Yeh, K.C., 2013. Iron is involved in the maintenance of circadian period length in Arabidopsis. Plant physiology, 161(3), pp.1409-1420.
|
|
C1=CC=C(C=C1)C(C2=CC=CC=C2)C(=O)N[C@H](CCCN=C(N)N)C(=O)NCC3=CC=C(C=C3)CNC(=O)N.C(=O)(C(F)(F)F)O |
none |
Phase shift via Y1 receptor antagonism in rodents
|
Neuropeptide Y Y1 receptor
|
Neuropeptide Y1 receptor binding
|
Cohen, S., Vainer, E., Matar, M.A., Kozlovsky, N., Kaplan, Z., Zohar, J., Mathé, A.A. and Cohen, H., 2015. Diurnal fluctuations in HPA and neuropeptide Y-ergic systems underlie differences in vulnerability to traumatic stress responses at different zeitgeber times. Neuropsychopharmacology, 40(3), pp.774-790.
|
|
CC1=C(C(=CC=C1)C(C)C2=CN=CN2)C |
Approved |
Altered expression of clock genes in mice
|
mPer2
,
mPer1
,
CRY1-PER2 complex
|
Core clock modulation
|
Huang, X., Lin, D., Sun, Y., Wu, A. and Wei, C., 2021. Effect of dexmedetomidine on postoperative sleep quality: a systematic review. Drug design, development and therapy, pp.2161-2170.
|
|
CC1C=CC=C(C(=O)NC2=C(C3=C(C4=C(C(=C3O)C)OC(C4=O)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)C5=C2N6C=CC(=CC6=N5)C)O)C |
Approved |
protective effects against cognitive impairment caused by circadian rhythm disruption
|
Microbiota
|
protect
|
Meng, D., Yang, M., Hu, L., Liu, T., Zhang, H., Sun, X., Wang, X., Chen, Y.U., Jin, Y.U. and Liu, R., 2022. Rifaximin protects against circadian rhythm disruption–induced cognitive impairment through preventing gut barrier damage and neuroinflammation. Journal of neurochemistry, 163(5), pp.406-418.
|
|
CCOC(=O)N1CCC(C1)CN(CC2=CC=C(C=C2)Cl)CC3=CC=C(S3)[N+](=O)[O-] |
not approved |
Phase stabilization and circadian gene modulation in mice
|
mPer2
,
REV-ERBα
,
Per2 expression
|
Agonist REV-ERB alpha
|
Solt, L.A., et al, 2012. Regulation of circadian behaviour and metabolism by synthetic REV-ERB agonists. Nature, 485(7396), pp.62-68.
,
Yang, M.Y., Lin, H.Y.H., Chen, Y.Y.M., Hu, M.L., Chen, I.Y. and Yang, C.H., 2025. Chronic low-dose REV-ERBs agonist SR9009 mitigates constant light-induced weight gain and insulin resistance via adipogenesis modulation. Biomedical Journal, p.100830.
|
|
C1CCC2(C1)CC(=O)N(C(=O)C2)CCCCN3CCN(CC3)C4=NC=CC=N4 |
Approved |
Phase advance and reduced amplitude in mice and hamsters
|
5-HT1A
|
Serotoninergic signaling
|
Smith, V.M., Iannatonne, S., Achal, S., Jeffers, R.T. and Antle, M.C., 2014. The serotonergic anxiolytic buspirone attenuates circadian responses to light. European Journal of Neuroscience, 40(10), pp.3512-3525.
|
|
C1=CC=C2C(=C1)C3=C4C2=CC5=CC=CC6=C5C4=C(C=C6)C=C3 |
none |
Circadian rhythm disruption in mammals
|
CLOCK-BMAL1
|
Disruption of circadian clock,
aryl hydrocarbon receptor (AhR) binding
|
Koh, Y.C. and Pan, M.H., 2024. Food-Borne Polycyclic Aromatic Hydrocarbons and Circadian Disruption. ACS omega, 9(29), pp.31298-31312.
|
|
CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)C(F)(F)F |
Approved |
Phase shift in fungi (Neurospora)
|
Calmodulin
|
Calmodulin binding (Neurospora)
|
Suzuki, S., Katagiri, S. and Nakashima, H., 1996. Mutants with altered sensitivity to a calmodulin antagonist affect the circadian clock in Neurospora crassa. Genetics, 143(3), pp.1175-1180.
|
|
CCOC(=O)C1CC2=CC=CC=C2CN1C(=O)C3=CC=C(S3)SC |
Not approved |
Amplitude enhancement and phase shift in human cells
|
CLOCK-BMAL1
|
Antagonist of Rev-Erb nuclear receptors,
de-repressing BMAL1
|
Kojetin, D., Wang, Y., Kamenecka, T.M. and Burris, T.P., 2011. Identification of SR8278, a synthetic antagonist of the nuclear heme receptor REV-ERB. ACS chemical biology, 6(2), pp.131-134.
,
Anabtawi, N., Cvammen, W. and Kemp, M.G., 2021. Pharmacological inhibition of cryptochrome and REV-ERB promotes DNA repair and cell cycle arrest in cisplatin-treated human cells. Scientific Reports, 11(1), p.17997.
|
|
C1=CC2=C3C(=C1)C4=CC=CC5=C4C6=C(C=C5)C=CC(=C36)C=C2 |
None |
Circadian rhythm disruption in mammals
|
mPer2
,
mPer1
,
CRY1-PER2 complex
,
CLOCK-BMAL1
|
Disruption of circadian clock,
Interferes with CLOCK–BMAL1,
aryl hydrocarbon receptor (AhR) binding
|
Koh, Y.C. and Pan, M.H., 2024. Food-Borne Polycyclic Aromatic Hydrocarbons and Circadian Disruption. ACS omega, 9(29), pp.31298-31312.
|
|
CN(C)CCCN1C2=CC=CC=C2SC3=CC=CC=C31 |
Approved |
Circadian rhythm disruption in humans
|
D2R (dopamine receptor)
|
Hypnotic effect,
Sleep promotion
|
Nagayama, H., Takagi, A., Sakurai, Y., Nishiwaki, K. and Takahashi, R., 1978. Chronopharmacological study of neuroleptics: II. Circadian susceptibility rhythm to chlorpromazine. Psychopharmacology, 58, pp.49-53.
|
|
CC1=C(OC2=C1C3=C(C=C2)OC(CC3=O)(C)C4=CC=C(C=C4)Cl)C(=O)N5CCC6=CC=CC=C65 |
Not approved |
Period lengthening in human cells (U2OS)
|
CRY1
|
Binds CRY1 FAD-binding
|
Gul, S., Akyel, Y.K., Gul, Z.M., Isin, S., Ozcan, O., Korkmaz, T., Selvi, S., Danis, I., Ipek, O.S., Aygenli, F. and Taskin, A.C., 2022. Discovery of a small molecule that selectively destabilizes Cryptochrome 1 and enhances life span in p53 knockout mice. Nature Communications, 13(1), p.6742.
|
|
C1=CC=C2C(=C1)C=CC3=CC4=C(C=CC5=CC=CC=C54)C=C32 |
none |
Circadian disruption via core clock interference (in mammals)
|
mPer2
,
mPer1
,
CRY1-PER2 complex
,
CLOCK-BMAL1
|
Disruption of circadian clock,
Bmal1,
Interferes with CLOCK–BMAL1,
aryl hydrocarbon receptor (AhR) binding
|
Koh, Y.C. and Pan, M.H., 2024. Food-Borne Polycyclic Aromatic Hydrocarbons and Circadian Disruption. ACS omega, 9(29), pp.31298-31312.
|
|
C1CN(CCC1N2C3=CC=CC=C3NC2=O)CCCC(C4=CC=C(C=C4)F)C5=CC=C(C=C5)F |
Approved |
Phase-dependent modulation of activity amplitude and onset (in rodents)
|
D2R (dopamine receptor)
|
Dopamine receptor binding
|
Davies, J.A., 1979. The Influence of Dopaminergic Mechanism on 24-Hour Temperature and Activity Rhythms in Rodents. In Neuro-Psychopharmacology (pp. 611-620). Pergamon.
|
|
C1CCC(CC1)N2C=NC(=C2C3=NC(=NC=C3)N)C4=CC=C(C=C4)F.Cl.Cl |
Not approved |
Period lengthening and phase delay in rodents and SCN slices
|
CK1δ
|
Inhibits CK1δ
|
Meng, Q.J., Maywood, E.S., Bechtold, D.A., Lu, W.Q., Li, J., Gibbs, J.E., Dupré, S.M., Chesham, J.E., Rajamohan, F., Knafels, J. and Sneed, B., 2010. Entrainment of disrupted circadian behavior through inhibition of casein kinase 1 (CK1) enzymes. Proceedings of the National Academy of Sciences, 107(34), pp.15240-15245.
|
|
C1=CC=C2C(=C1)C=CC3=C2C=CC4=CC=CC=C43 |
none |
Circadian disruption via core clock targeting in mammals
|
mPer2
,
mPer1
,
CRY1-PER2 complex
,
CRY1
,
CLOCK-BMAL1
|
Disruption of circadian clock,
Bmal1,
modulation of nuclear receptor signaling pathways,
Interferes with CLOCK–BMAL1,
Targets BMAL1–CLOCK DNA-binding activity
|
Koh, Y.C. and Pan, M.H., 2024. Food-Borne Polycyclic Aromatic Hydrocarbons and Circadian Disruption. ACS omega, 9(29), pp.31298-31312.
|
|
C1CCC(C(C1)CN2CCN(CC2)C3=NSC4=CC=CC=C43)CN5C(=O)C6C7CCC(C7)C6C5=O |
Approved |
Clock gene normalization and potential phase shift in rats
|
mPer2
,
mPer1
,
CRY1-PER2 complex
,
CRY1
,
CLOCK-BMAL1
,
Arntl (gene)
|
Core clock modulation
|
Calabrese, F., Savino, E., Papp, M., Molteni, R. and Riva, M.A., 2016. Chronic mild stress-induced alterations of clock gene expression in rat prefrontal cortex: modulatory effects of prolonged lurasidone treatment. Pharmacological research, 104, pp.140-150.
,
Krystal, A.D. and Zammit, G., 2016. The sleep effects of lurasidone: a placebo‐controlled cross‐over study using a 4‐h phase‐advance model of transient insomnia. Human Psychopharmacology: Clinical and Experimental, 31(3), pp.206-216.
|
|
C1=CC=C2C=C3C4=CC=CC5=C4C(=CC=C5)C3=CC2=C1 |
none |
Circadian disruption via core clock gene targeting in animals (PAH exposure model)
|
mPer2
,
mPer1
,
CRY1-PER2 complex
,
CRY1
,
CLOCK-BMAL1
|
Disruption of circadian clock,
Bmal1,
Interferes with CLOCK–BMAL1,
Targets BMAL1–CLOCK DNA-binding activity,
aryl hydrocarbon receptor (AhR) binding
|
Koh, Y.C. and Pan, M.H., 2024. Food-Borne Polycyclic Aromatic Hydrocarbons and Circadian Disruption. ACS omega, 9(29), pp.31298-31312.
|
|
C1CN(CCN1CCC=C2C3=CC=CC=C3SC4=C2C=C(C=C4)C(F)(F)F)CCO |
Approved |
Circadian disruption in humans (rest-activity rhythm disturbance with flupentixol)
|
Unknown
|
Unknown,
5-HT7 binding
|
Dagan, Y. and Borodkin, K., 2005. Behavioral and psychiatric consequences of sleep-wake schedule disorders. Dialogues in clinical neuroscience, 7(4), pp.357-365.
,
Bad News for Antipsychotics and Circadian Rhythms
|
|
CCCCCC1=CC(=C2C(=C1)OC(C3=C2C=C(C=C3)C)(C)C)O |
Not approved |
Circadian modulation potential via CB2 in mammals (indirect, immune-related pathways)
|
Cannabinoid receptor
,
CB2
|
Disruption of circadian clock,
Core clock modulation,
Unknown,
Cannabinoid receptor stimulation
|
Lafaye G, Desterke C, Marulaz L, Benyamina A. Cannabidiol affects circadian clock core complex and its regulation in microglia cells. Addiction Biology. 2018.
|
|
CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3 |
Approved |
restores normal circadian rhythms,
shifted the phases
|
T58921 Peroxisome proliferator-activated receptor gamma (PPAR-gamma)
,
BMAL1 expression (induction)
,
CLOCK gene expression
|
protect
|
Tian, Y., Luan, X. and Yang, K., 2024. Chronotherapy involving rosiglitazone regulates the phenotypic switch of vascular smooth muscle cells by shifting the phase of TNF-α rhythm through triglyceride accumulation in macrophages. Heliyon, 10(10), p.e30708.
,
Tian, Y., Luan, X. and Yang, K., 2024. Chronotherapy involving rosiglitazone regulates the phenotypic switch of vascular smooth muscle cells by shifting the phase of TNF-α rhythm through triglyceride accumulation in macrophages. Heliyon, 10(10), p.e30708.
|